# Safety & Efficacy of RenalGuard® Therapy in the Prevention of Cardiac Surgery Associated Acute Kidney Injury

> **NCT07123935** · NA · NOT_YET_RECRUITING · sponsor: **CardioRenal Systems, Inc.** · enrollment: 300 (estimated)

## Conditions studied

- Cardiac Surgery Associated - Acute Kidney Injury
- AKI - Acute Kidney Injury

## Interventions

- **DEVICE:** RenalGuard® Therapy
- **OTHER:** Standard of Care (SOC)

## Key facts

- **NCT ID:** NCT07123935
- **Lead sponsor:** CardioRenal Systems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-08-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07123935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07123935, "Safety & Efficacy of RenalGuard® Therapy in the Prevention of Cardiac Surgery Associated Acute Kidney Injury". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07123935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*